Stem cell agency, BioTime strike deal
BioTime Inc. will make five clinical-grade human embryonic stem cell lines available to California researchers, according to a deal between the Alameda company and California’s stem cell research funding agency, that could smooth the translation of stem …
[Read the full article here]